James J. Stragand

495 total citations
20 papers, 402 citations indexed

About

James J. Stragand is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James J. Stragand has authored 20 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James J. Stragand's work include Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). James J. Stragand is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). James J. Stragand collaborates with scholars based in United States and Canada. James J. Stragand's co-authors include Ronald F. Hagemann, Paul G. Braunschweiger, Lewis M. Schiffer, Benjamin Drewinko, Barbara Fleming, José M. Trujillo, Barthel Barlogie, Liying Yang, Lawrence Poulakos and B. Jansson and has published in prestigious journals such as Cancer, Journal of Nutrition and British Journal of Cancer.

In The Last Decade

James J. Stragand

19 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James J. Stragand United States 12 130 116 74 65 58 20 402
Rihong Cong China 13 127 1.0× 177 1.5× 53 0.7× 72 1.1× 49 0.8× 14 599
L Jakab Hungary 10 38 0.3× 112 1.0× 89 1.2× 51 0.8× 24 0.4× 46 464
B. Perdereau France 8 59 0.5× 132 1.1× 56 0.8× 22 0.3× 31 0.5× 15 484
Jarosław Szefel Poland 12 133 1.0× 123 1.1× 37 0.5× 65 1.0× 45 0.8× 25 374
Kiyowo Kosaka Japan 11 47 0.4× 172 1.5× 94 1.3× 64 1.0× 41 0.7× 32 462
Longnecker Ds 10 141 1.1× 76 0.7× 100 1.4× 30 0.5× 16 0.3× 16 355
Harry W. Carter United States 8 69 0.5× 211 1.8× 51 0.7× 72 1.1× 19 0.3× 11 459
Giuseppe Pietra United States 12 52 0.4× 102 0.9× 75 1.0× 90 1.4× 23 0.4× 15 490
Keiichiro Genka Japan 12 183 1.4× 164 1.4× 85 1.1× 78 1.2× 31 0.5× 24 529
Rajalakshmi Nair United States 9 152 1.2× 279 2.4× 123 1.7× 113 1.7× 57 1.0× 10 549

Countries citing papers authored by James J. Stragand

Since Specialization
Citations

This map shows the geographic impact of James J. Stragand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Stragand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Stragand more than expected).

Fields of papers citing papers by James J. Stragand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. Stragand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Stragand. The network helps show where James J. Stragand may publish in the future.

Co-authorship network of co-authors of James J. Stragand

This figure shows the co-authorship network connecting the top 25 collaborators of James J. Stragand. A scholar is included among the top collaborators of James J. Stragand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Stragand. James J. Stragand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schiffer, Lewis M., Paul G. Braunschweiger, & James J. Stragand. (2015). Tumor Cell Population Kinetics Following Noncurative Treatment1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 23. 148–156. 1 indexed citations
2.
Weaver, Gary A., Jean A. Krause, James J. Stragand, et al.. (2000). Biomarkers of Human Colonic Cell Growth Are Influenced Differently by a History of Colonic Neoplasia and the Consumption of Acarbose. Journal of Nutrition. 130(11). 2718–2725. 24 indexed citations
3.
Weaver, Gary A., et al.. (1996). Dietary Guar Gum Alters Colonic Microbial Fermentation in Azoxymethane-Treated Rats. Journal of Nutrition. 126(8). 1979–1991. 21 indexed citations
4.
Stragand, James J., et al.. (1990). Mallory-Weiss Tear Complicating Intraoperative Transesophageal Echocardiography in a Patient Undergoing Aortic Valve Replacement. Anesthesiology. 73(4). 777–778. 36 indexed citations
5.
Drewinko, Benjamin, Liying Yang, Albert Leibovitz, et al.. (1984). Cellular discriminants for a biological classification of human colon carcinoma.. PubMed. 44(10). 4241–53. 48 indexed citations
6.
Drewinko, Benjamin, Wendy M. Mars, James J. Stragand, et al.. (1984). ARH-77, an established human IgG-producing myeloma cell line. II. growth kinetics, clonogenic capacity, chalone production, xenogeneic transplantations, and response to melphalan. Cancer. 54(9). 1893–1903. 12 indexed citations
7.
Grdina, David J., R. Allen White, & James J. Stragand. (1983). Cytotoxic effects of vincristine on tumour subpopulations separated from pulmonary nodules. British Journal of Cancer. 48(2). 279–287. 1 indexed citations
8.
Stragand, James J., et al.. (1982). Growth characteristics of human colonic adenocarcinomas propagated in the Rowett athymic rat.. PubMed. 42(8). 3111–5. 14 indexed citations
9.
Stragand, James J., Liying Yang, & Benjamin Drewinko. (1980). Serum CEA levels in a human colonic adenocarcinoma (LOVO) xenograft system. Cancer Letters. 10(1). 45–50. 10 indexed citations
10.
Stragand, James J., et al.. (1980). Biological and cell kinetic properties of a human colonic adenocarcinoma (LoVo) grown in athymic mice.. PubMed. 40(8 Pt 1). 2846–52. 23 indexed citations
11.
Stragand, James J., et al.. (1980). A procedure for the application of cell kinetic techniques to human tumor samples. European Journal of Cancer (1965). 16(2). 293–295. 2 indexed citations
12.
Stragand, James J., Paul G. Braunschweiger, Agnese A. Pollice, & Lewis M. Schiffer. (1979). Cell kinetic alterations in murine mammary tumors following fasting and refeeding. European Journal of Cancer (1965). 15(3). 281–286. 20 indexed citations
13.
Schiffer, Lewis M., Paul G. Braunschweiger, James J. Stragand, & Lawrence Poulakos. (1979). The cell kinetics of human mammary cancers. Cancer. 43(5). 1707–1719. 34 indexed citations
14.
Stragand, James J., et al.. (1979). Fasting and refeeding.. The Mouseion at the JAXlibrary (Jackson Laboratory). 281. 7 indexed citations
15.
Stragand, James J. & Ronald F. Hagemann. (1978). Effect of parathyroidectomy on the fasting-refeeding response in the rat colon. Cellular and Molecular Life Sciences. 34(2). 189–190. 1 indexed citations
16.
Braunschweiger, Paul G., James J. Stragand, & Lewis M. Schiffer. (1978). Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors.. PubMed. 38(12). 4510–4. 13 indexed citations
17.
Stragand, James J. & Ronald F. Hagemann. (1978). An Iron Requirement For the Synchronous Progression of Colonic Cells Following Fasting and Refeeding. Cell Proliferation. 11(5). 513–518. 9 indexed citations
18.
Stragand, James J. & Ronald F. Hagemann. (1977). Effect of lumenal contents on colonic cell replacement.. American Journal of Physiology-Endocrinology and Metabolism. 233(3). E208–E208. 31 indexed citations
19.
Hagemann, Ronald F. & James J. Stragand. (1977). FASTING AND REFEEDING: CELL KINETIC RESPONSE OF JEJUNUM, ILEUM AND COLON. Cell Proliferation. 10(1). 3–14. 94 indexed citations
20.
Stragand, James J. & Ronald F. Hagemann. (1975). A technical improvement in the radioimmunoassay of cyclic-AMP. Cellular and Molecular Life Sciences. 31(11). 1375–1376. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026